Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

014 Hydrophilic Coated PTA Balloon Dilatation Catheter

K-Number: K171251 · 2017-09-08

ApplicantCreagh Medical
Decision Date2017-09-08
Product CodeLIT
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

014 Hydrophilic Coated PTA Balloon Dilatation Catheter is a medical device manufactured by Creagh Medical. It received FDA 510(k) clearance on 2017-09-08 under approval number K171251. The device is classified under product code LIT. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the 014 Hydrophilic Coated PTA Balloon Dilatation Catheter?

014 Hydrophilic Coated PTA Balloon Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2017-09-08. It is manufactured by Creagh Medical. The 510(k) number is K171251.

When was 014 Hydrophilic Coated PTA Balloon Dilatation Catheter approved by the FDA?

014 Hydrophilic Coated PTA Balloon Dilatation Catheter received FDA 510(k) clearance on 2017-09-08, under approval number K171251.

What company makes 014 Hydrophilic Coated PTA Balloon Dilatation Catheter?

014 Hydrophilic Coated PTA Balloon Dilatation Catheter is manufactured by Creagh Medical.

What is the FDA product code for 014 Hydrophilic Coated PTA Balloon Dilatation Catheter?

The FDA product code for 014 Hydrophilic Coated PTA Balloon Dilatation Catheter is LIT.

Related Clinical Trials

NCT07614100 Cerebral Microembolization During Transcatheter Aortic Valve Implantation: Comparing Balloon-expandable and Self-expanding Valves NOT_YET_RECRUITING NCT06353594 Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI RECRUITING NCT05846893 Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT04647253 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) ACTIVE_NOT_RECRUITING NCT06492174 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort ACTIVE_NOT_RECRUITING NCT07214948 Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction NOT_YET_RECRUITING

Related PubMed Literature

PMID: 25499024 Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix® drug coated balloon. Cardiovascular revascularization medicine : including molecular interventions (2014)

Related Devices (Code: LIT)

K160941Castor, Achilles and Hermes NC PTA Balloon Dilatation CatheterBrosmed Medical Co., Ltd. K162316Pirouette 014Arravasc, Ltd. K162350Coyote Monorail Percutaneous Transluminal Angioplasty Balloon Dilatation Catheter, Express SD Biliary Monorail Premounted Stent System, Maverick XL Percutaneous Transluminal Coronary Angioplasty Monorail Dilatation Catheter, Sterling Monorail Percutaneous Transluminal Angioplasty Balloon Dilatation Catheter, Ultra-Soft SV Monorail Balloon Dilatation Catheter 0.018Boston Scientific Corporation K161427Pirouette 035Arravasc Limited K160256Polux , Minerva and Atropos PTA Balloon Dilatation CatheterBrosmed Medical Co., Ltd. K160004Crosstella OTWKANEKA Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑